Intercalated combination of chemotherapy and erlotinib for stage IIIA non-small-cell lung cancer: a multicenter, open-label, single-arm, phase II study

OBJECTIVE: This multicenter, open-label, single-arm, phase II trial evaluated the efficacy and safety of an intercalated combination of erlotinib and gemcitabine/cisplatin or carboplatin in patients with stage IIIA non-small-cell lung cancer (NSCLC). REGISTRATION: This trial is registered with Clini...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Manag Res
Main Authors: Chen, Zhiwei, Shen, Shengping, Shi, Wenbo, Jiang, Gening, Wang, Xin, Jian, Hong, Zhou, Zhen, Ding, Zhengping, Lu, Shun
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2019
Assuntos:
Clinical Trial Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6636178/
https://ncbi.nlm.nih.gov/pubmed/31372055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S189287
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados